Colchicine may reduce myocardial damage after non-bypass heart surgery.

Published Date: 17 Feb 2023

China: Low-dose colchicine helps protect myocardium in surgery patients without CABG (coronary artery bypass graft).

Read Full News

Latest News

SCS Closures in Ontario Spark Harm Reduction Concerns

Ontario will replace nine supervised consumption sites with HART hubs, but critics warn the lack of harm reduction could increase overdoses and strain emergency services.

Two EMA Moves Broaden Options in Hemophilia, Iron Deficiency

The European Medicines Agency has backed Feraccru for adolescent iron deficiency and expanded Hympavzi prophylaxis to hemophilia patients with or without inhibitors.

EU Panel Expands Options in Relapsed Childhood Leukemia

The proposed EU expansion would extend access to Besponsa, a CD22-directed therapy in children with relapse of acute lymphoblastic leukemia or in whom prior treatment has failed.

Zoster Vaccine Uptake Low in Rheumatic Disease in the US

Recombinant zoster vaccine uptake in adults with rheumatic disease reached around 10% in the 20 months following the updated 2021 recommendations, with lack of tracking and education seen as barriers.

Emerging Norovirus Vaccines Face Scientific, Policy Hurdles

Researchers are advancing several norovirus vaccine candidates, such as oral tablet-based platforms, mRNA vaccines, and virus-like particle technologies.

Fibromyalgia Reframed and Linked to Altered Pain Processing

The condition is best understood as a symptom-based disorder of altered pain processing with partial overlap with post-viral syndrome, but important distinctions remain.

Todays Updates

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

A dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.

Todays Updates

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

A dose-dense modified Stanford V regimen may improve early complete responses and allow some pediatric patients with low-risk Hodgkin lymphoma to skip radiotherapy.

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated with reduced treatment response.

Latest News

Ontario will replace nine supervised consumption sites with HART hubs, but critics warn the lack of harm reduction could increase overdoses and strain emergency services.

The European Medicines Agency has backed Feraccru for adolescent iron deficiency and expanded Hympavzi prophylaxis to hemophilia patients with or without inhibitors.

The proposed EU expansion would extend access to Besponsa, a CD22-directed therapy in children with relapse of acute lymphoblastic leukemia or in whom prior treatment has failed.

Recombinant zoster vaccine uptake in adults with rheumatic disease reached around 10% in the 20 months following the updated 2021 recommendations, with lack of tracking and education seen as barriers.

Researchers are advancing several norovirus vaccine candidates, such as oral tablet-based platforms, mRNA vaccines, and virus-like particle technologies.

The condition is best understood as a symptom-based disorder of altered pain processing with partial overlap with post-viral syndrome, but important distinctions remain.

News All Time

EU Backs New Oral Option in Psoriatic Arthritis

The European Medicines Agency has endorsed expanded use of Sotyktu for psoriatic arthritis, recommending approval after clinical trials showed improvement in joint symptoms.

What We Thought We Knew About the Thymus May Be Wrong

The seemingly unassuming organ has become an emerging target for healthspan, longevity, and precision oncology.

Anifrolumab Shows Promise in Real-World Lupus Care

Anifrolumab treatment is linked to improved disease activity and reduced steroid use and has an acceptable safety profile in routine care of patients with systemic lupus erythematosus.

The Death of the Medical Fax Is Foretold — Again

Medical offices are sick and tired of faxing, and federal officials agree. But modernization won’t be easy.

Rare Immune Disorder Drug Wins EU Panel Support

EMA’s panel backs a targeted therapy, which reduces lymphadenopathy and restores B-cell populations in patients with activated phosphoinositide 3-kinase delta syndrome.

Food-Allergic Adults May Shun Nonallergenic Items

Because of fear of allergic reactions, some patients need psychological counseling and dietary support for a more positive attitude toward food.

Roflumilast Promising for AD in Children Down to Age 3 Mos

Global assessment and itch/scratch scores highlight the effectiveness of topical roflumilast for treating atopic dermatitis in children 3 months to 2 years old, in a phase 2 study.

Upadacitinib Significantly Improves Vitiligo vs Placebo

The JAK1 inhibitor in development for treating nonsegmental vitiligo was superior to placebo on investigator ratings in two phase 3 trials.

Adrenal Crisis: Rare, Deadly, Preventable — Here’s How

Adrenal crisis remains rare but life-threatening. Better patient, family, and clinician education could help prevent deaths.

Psychosocial Factors May Improve ED Suicide Risk Prediction

Augmentation of data-based risk models with psychosocial factors obtained from clinical notes may improve the prediction of suicide attempts in patients with suicidal ideation, a study shows.

Mar 27 2026 This Week in Cardiology

Early aortic valve replacement in aortic stenosis, left atrial appendage occlusion in JAMA Cardiology, and a big preview of the upcoming American College of Cardiology meeting are the topics John Mandrola, MD, discusses in this week’s podcast.

South Carolina Could Declare Measles Outbreak Over by April 26, Health Official Says

South Carolina could declare its ongoing measles ⁠outbreak over by April 26 if no additional infections are reported, the state's ⁠top epidemiologist said during a briefing...

Allergic Rhinitis May Worsen Asthma Risk in CRS

Individuals with chronic rhinosinusitis face an elevated risk of developing new-onset asthma and subsequent exacerbations, and concurrent allergic rhinitis increases the risk.

EU Chemicals Agency Backs Ban on PFAS 'Forever Chemicals'

The European Chemicals Agency on Thursday recommended a broad EU-wide ban on PFAS, or "forever chemicals," with some ⁠exemptions.

A Ubiquitous Alcohol Emerges as Allergen of 2026

Benzyl alcohol, though generally safe, can be a stealth cause of allergic dermatitis through a variety of exposures.

Survey Examines Current Practice in Skin of Color Clinics

Clinics dedicated to treating patients with skin of color are increasingly common, but a survey suggests they are addressing this need with limited or no institutional support.

Recommended News For You

Children living near oil and gas wells face higher risk of rare leukemia, studies show

Study Supports More Inclusive Clinical Trials With Broader Eligibility Criteria

Muscle Strength, Fitness Linked to Lower Mortality Risk in Patients With Cancer

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

Waiting for a Sharp Increase in Prostate Cancer Cases.

Slowdown in progress found with cancer survival in England and Wales

Can Oligonucleotide Infusions Really Fix Lyme, Cancer, and Other Diseases?

Recommended Articles For You

New Anticoagulants: Balancing Efficacy and Safety in Patients with Atrial Fibrillation 

Beyond the Blood: Expanding CAR T-Cell Therapy to Solid Tumors- A New Era of Precision Oncology 

Claudin-18.2 in Gastric Cancer: Tumor-Stroma Crosstalk and Disease Progression 

Treating Methemoglobinemia: What You Need to Know Now! 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Advances in TNBC; Mixed News in Lung Cancer Report; Pancreatic Cancer Overdiagnosis?

2.

For Localized Prostate Cancer, HIFU Is Not Worse Than Prostatectomy.

3.

Reducing social media to an hour a day boosts young people's self-image.

4.

Squeezing through tiny blood vessels may trigger melanoma cells to spread

5.

Despite reports of hundreds of cancer cases, carcinogens have been discovered at nuclear missile sites in Montana.

1.

Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations

2.

Lymphomatoid Papulosis: What You Need to Know

3.

The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder 

4.

Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights

5.

AI Revolutionizes Immunotherapy: Unveiling Biomarkers with Machine Intelligence

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients

2.

ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis

3.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI

4.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII

5.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot